Skip to content

The impact of taking aspirin early on heart attack treatment and recovery.

Comparison of angiographic and in-hospital outcomes in patients presenting with acute coronary syndrome with or without aspirin pre-treatment. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/085245
Enrollment
140
Registered
2025-04-21
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B- Imaging

Interventions

Intervention1: Nil: Nil Intervention2: Patients receiving Aspirin: Prior to presentation as ACS patients receiving aspirin within 30 days will be considered for the study Control Intervention1: Patien

Sponsors

Manipal Academy of Higher Education
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age more than 18 years Diagnosed with ACS Type 1 MI who meet the criteria of ACC/AHA guidelines Patients who are pretreated and not pre treated with aspirin for at least 30 days prior to admission

Exclusion criteria

Exclusion criteria: Prior treatment with antiplatelets other than aspirin, for example clopidogrel, prasugrel or others Severe scale of physical disability or difficulty in understanding the study Mechanical complications of MI

Design outcomes

Primary

MeasureTime frame
To compare the angiographic outcomes, including TIMI flow grade and thrombus burden by Gibson score, and in-hospital outcomes in patients presenting with ACS with or without aspirin pre-treatment.Timepoint: 3 days

Secondary

MeasureTime frame
To compare the plaque characteristics at the site of occlusion in the culprit lesion by using QCA and IVUS.Timepoint: 3 days

Countries

India

Contacts

Public ContactDr Krishnananda Nayak

Manipal College of Health Profession

krishnananda.n@manipal.edu9964015487

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026